- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.58 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 9WH: 5-[(5-azanyl-3-methyl-pyrazol-1-yl)methyl]-~{N}-[1-[(2-chloranyl-6-fluoranyl-phenyl)methyl]pyrazol-3-yl]-1,3,4-thiadiazol-2-amine(Non-covalent)
9WH.1: 17 residues within 4Å:- Chain A: G.96, F.97, M.98, Q.100, M.103, G.104, F.149, A.157, Y.158, M.161, T.196, A.198, M.199, I.202, L.207, I.215
- Ligands: NAD.2
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:F.149, A:A.157, A:Y.158, A:I.215
- Hydrogen bonds: A:M.98, A:M.98
- Water bridges: A:T.196
- pi-Stacking: A:Y.158
9WH.3: 17 residues within 4Å:- Chain B: G.96, F.97, M.98, Q.100, M.103, G.104, F.149, A.157, Y.158, M.161, T.196, A.198, M.199, A.206, L.207, I.215
- Ligands: NAD.4
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:Q.100, B:F.149, B:A.157, B:Y.158, B:I.215
- Hydrogen bonds: B:M.98, B:M.98
- Water bridges: B:T.196
- pi-Stacking: B:Y.158
9WH.5: 15 residues within 4Å:- Chain C: G.96, F.97, M.98, Q.100, M.103, G.104, F.149, A.157, Y.158, M.161, M.199, I.202, L.207, I.215
- Ligands: NAD.6
10 PLIP interactions:10 interactions with chain C- Hydrophobic interactions: C:Q.100, C:M.103, C:F.149, C:A.157, C:Y.158, C:I.202, C:I.215
- Hydrogen bonds: C:M.98, C:M.98
- pi-Stacking: C:Y.158
9WH.7: 15 residues within 4Å:- Chain D: G.96, F.97, M.98, Q.100, M.103, G.104, F.149, A.157, Y.158, M.161, M.199, I.202, L.207, I.215
- Ligands: NAD.8
9 PLIP interactions:9 interactions with chain D- Hydrophobic interactions: D:M.103, D:F.149, D:A.157, D:Y.158, D:I.202, D:I.215
- Hydrogen bonds: D:M.98, D:M.98
- pi-Stacking: D:Y.158
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.2: 23 residues within 4Å:- Chain A: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, K.165, A.191, G.192, P.193, I.194, T.196
- Ligands: 9WH.1
22 PLIP interactions:22 interactions with chain A- Hydrophobic interactions: A:I.21, A:F.149, A:F.149, A:A.191
- Hydrogen bonds: A:G.14, A:S.20, A:I.21, A:D.64, A:V.65, A:I.95, A:G.96, A:K.165, A:I.194, A:I.194, A:T.196, A:T.196
- Water bridges: A:G.14, A:A.22, A:F.41, A:I.95
- pi-Stacking: A:F.41, A:F.41
NAD.4: 24 residues within 4Å:- Chain B: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, K.165, A.191, G.192, P.193, I.194, T.196, M.199
- Ligands: 9WH.3
22 PLIP interactions:22 interactions with chain B- Hydrophobic interactions: B:F.149, B:A.191
- Hydrogen bonds: B:G.14, B:I.21, B:D.64, B:D.64, B:V.65, B:I.95, B:G.96, B:K.165, B:I.194, B:I.194, B:T.196, B:T.196
- Water bridges: B:G.14, B:A.22, B:F.41, B:I.95, B:L.197, B:A.198
- pi-Stacking: B:F.41, B:F.41
NAD.6: 23 residues within 4Å:- Chain C: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, K.165, A.191, G.192, P.193, I.194, T.196
- Ligands: 9WH.5
20 PLIP interactions:20 interactions with chain C- Hydrophobic interactions: C:I.21, C:F.149, C:F.149
- Hydrogen bonds: C:G.14, C:I.21, C:D.64, C:V.65, C:I.95, C:G.96, C:K.165, C:I.194, C:I.194, C:T.196
- Water bridges: C:G.14, C:A.22, C:I.95, C:T.196, C:L.197
- pi-Stacking: C:F.41, C:F.41
NAD.8: 23 residues within 4Å:- Chain D: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, K.165, A.191, G.192, P.193, I.194, T.196
- Ligands: 9WH.7
18 PLIP interactions:18 interactions with chain D- Hydrophobic interactions: D:I.21, D:F.149, D:F.149, D:A.191
- Hydrogen bonds: D:G.14, D:I.21, D:D.64, D:D.64, D:V.65, D:I.95, D:G.96, D:K.165, D:I.194, D:I.194
- Water bridges: D:A.22, D:I.95, D:T.196
- pi-Stacking: D:F.41
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Prati, F. et al., Screening of a Novel Fragment Library with Functional Complexity against Mycobacterium tuberculosis InhA. ChemMedChem (2018)
- Release Date
- 2018-02-14
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
DC
FD
H
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.58 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x 9WH: 5-[(5-azanyl-3-methyl-pyrazol-1-yl)methyl]-~{N}-[1-[(2-chloranyl-6-fluoranyl-phenyl)methyl]pyrazol-3-yl]-1,3,4-thiadiazol-2-amine(Non-covalent)
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Prati, F. et al., Screening of a Novel Fragment Library with Functional Complexity against Mycobacterium tuberculosis InhA. ChemMedChem (2018)
- Release Date
- 2018-02-14
- Peptides
- Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
DC
FD
H